Sophoridine (0-500 μM; 48 hours) exhibits remarkable inhibition effects to the growth of human pancreatic, gastric, liver, colon, gallbladder, and prostate carcinoma cells with IC50 values of about 20 μM to 200 μM.
Sophoridine (0-20 μM; 48 hours) increases S phase cell population from 26.23% (control) to 38.67% in Miapaca-2 cells and from 29.56% (control) to 39.16% in PANC-1 cells, about a 1.5-fold and a 1.3-fold increase, respectively.
Sophoridine (0-20 μM; 48 hours) significantly increases bad and bax levels, and decreases bcl-2 and bcl-xl levels in contrast, with a significant increase in Bax/Bcl-2 ratio.
Medlife has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Viability Assay
Cell Line: |
Normal cells: IOSE144, HL-7702 and LO2, BEAS-2B, GES-1, HEK 293 T, HPDE, FHC, Human cancer cells: PANC-1, Mapaca-1, hepG2, SGC-7901, CBC-SD,SGC-996,PC-3,MKN-45,MGC-803,Hela and HCT116 cells |
Concentration: |
0, 3.9, 7.8, 15.5, 31, 62.5, 125, 250, 500 μM |
Incubation Time: |
48 hours |
Result: |
Exhibited the most potent cytotoxicity to cancer cells. |
Cell Cycle Analysis
Cell Line: |
PANC-1 cells; Miapca-2 cells |
Concentration: |
20 μM |
Incubation Time: |
48 hours |
Result: |
Led to accumulated population in the S phase. |
Western Blot Analysis
Cell Line: |
PANC-1 cells; Miapca-2 cells |
Concentration: |
20 μM |
Incubation Time: |
48 hours |
Result: |
Induced the activation of intrinsic apoptosis pathway. |